Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

IN8bio's INB-400, INB-410 GMB Treatments Designated Orphan Drug by FDA

IN8bio's INB-400, INB-410 GMB Treatments Designated Orphan Drug by FDA

IN8bio Inc. on Tuesday said INB-400 and INB-410 received the U.S. Food and Drug Administration's orphan drug designation for a range of malignant glioma treatments, including newly diagnosed glioblastoma multiforme.

Glioblastoma multiforme is an aggressive and difficult to treat brain cancer. The FDA in December cleared the New York-based clinical-stage biopharmaceutical company's investigational new drug application for a Phase 2 clinical trial of INB-400 for treatment of glioblastoma multiforme.

IN8bio said patient enrollment in the Phase 2 trial of INB-400 is expected to begin in the second half of 2023, with an Institutional Review Board review and site initiation ongoing.

Apr 25, 2023

https://www.morningstar.com/


0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies